|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Note receivable, net of discount of $0 and $4,716 at December 31, 2023 and 2022, respectively | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Bank overdraft | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Unearned interest | ||||||||||||||||||||
| Notes payable - current | ||||||||||||||||||||
| Shares payable to related parties | ||||||||||||||||||||
| Salaries payable to related parties | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Total derivative liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Notes payable, net of current | ||||||||||||||||||||
| Due to stockholders | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Temporary equity, value | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Total temporary equity, value | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series E Preferred Stock | ||||||||||||||||||||
| Common Stock $0.001 Par Value, 10,000,000,000 shares authorized; 586,385,063 shares and 586,285,063 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders' Equity (Deficit) | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity (Deficit) | ||||||||||||||||||||
Loading...